Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: Attenuation of diabetic nephropathy in rats

Journal of Physiology and Biochemistry

Volumn 68, Issue 2, 2012, Pages 263-269

  Sayed, Ahmed Amir Radwan ^a,b   Khalifa, Mahmoud ^b   Abd El Latif, Fathy Fahim ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Minia University ^*  (Egypt)

Author keywords

Diabetic nephropathy; Fenugreek; Metformin; Rosiglitazone

Indexed keywords

ANTIDIABETIC AGENT; CATALASE; HERBACEOUS AGENT; INTERLEUKIN 6; MALONALDEHYDE; METFORMIN; ROSIGLITAZONE; SUPEROXIDE DISMUTASE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; EXPERIMENTAL ANIMAL; FENUGREEK; GLUCOSE BLOOD LEVEL; KIDNEY FUNCTION; MESANGIUM; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; SODIUM BLOOD LEVEL; UREA BLOOD LEVEL;

ALLOXAN; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLUTATHIONE; INTERLEUKIN-6; KIDNEY; LIPID PEROXIDATION; MALONDIALDEHYDE; METFORMIN; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES; TRIGONELLA;

ANIMALIA; RATTUS; TRIGONELLA FOENUM-GRAECUM;

EID: 84864046227     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0139-6     Document Type: Article

References (28)

1. Abdel-Bary JA, Abdel Hassan IA, Al-Hakiem MHH (1997) Hypoglycemic and antihyperglycemic effect of Trigonella foenum graecum leaf in normal and alloxan induced diabet-ic rats. J Ethnopharmacol 58:149-155
2. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
3. Al-Shamanty J, Shahba M, Al Khazraji Twaij HAA (1994) Hypoglycemic effect of Artemisia herb alba II. Effect of a valuable extract on some blood parameters in diabetic ani-mals. J Ethnopharmacol 43:167-171
4. Ankrah NA (1995) Alterations ofglucose tolerance in mice fed low levels of aflatoxins and with depressed glyoxalase I activity Vet Hum Toxicol 37:59-61
5. Ashokkumar N, Pari L (2005) Effect of N-benzoyl-d-phe-nylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 351:105-113 (Pubitemid 39563563)
6. Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, De Mey JG, Schalkwijk CG (2010) Hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is medi-ated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53:989-1000
7. Choudhary D, Chandra D, Choudhary S, Kale RK (2001) Modulation of glyoxalase, glutathione S-transferase and antioxidant enzymes in the liver, spleen and erythrocytes ofmice by dietary administration offenugreek seeds. Food Chem Toxicol 39:989-997 (Pubitemid 32778450)
8. Ethan-Basch CU, Kuo G, Szapary P, Smith M (2003) Ther-apeutic applications offenugreek. Altern Med Rev 8:20-27
9. Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N (1996) Evaluation of glomerular lesion and abnormal urinary find-ings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 128:568-578 (Pubitemid 27506763)
10. Hamden K, Masmoudi H, Carreau S, Elfeki A (2010) Im-munomodulatory, ß-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes. Immunophar-macol Immunotoxicol Immunopharmacol Immunotoxicol 32:437-445
11. Hannan JMA, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YA (2007) Soluble dietary fiber fraction of Trigonella foenum graecum (fenugreek) seed improves glucose homeostasis in animal models oftype 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 97:514-521 (Pubitemid 46662041)
12. Haque N, Salma U, Nurunnabi TR, Uddin MJ, Jahangir MF, Islam SM, Kamruzzaman M (2011) Management oftype 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pak J Biol Sci 14:13-24
13. Kanter M (2009) Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Hist 40:107-115
14. Mao Z, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y (2009) Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal monocyte chemoattractant protein-1 expression. J Diabe-tes Complications 23:124-129
15. Morcos SR, Elhawary Z, Gabrial GN (1981) Protein rich food mixtures for feeding the young in Egypt. 1. Formula-tion. Z Ernährungswiss 20:275-282 (Pubitemid 12131291)
16. Morcos M, Sayed AAR, Bierhaus A, Yard B, Waldherr R Merz W, Kloeting I, Schleicher E, Mentz S, el Baki RFAbd, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt A-M, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP (2002) Activation of tubular epithelial cells in diabetic nephropathy Diabetes 51:3532-3544 (Pubitemid 35403461)
17. Morcos M, Schlotterer A, Sayed AAR, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G Jr, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A (2008) Rosi-glitazone reduces angiotensin ii and advanced glycation end product-dependent sustained nuclear factor-κB acti-vation in cultured human proximal tubular epithelial cells. Horm Metab Res 40:752-759
18. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 67:582-589
19. Nishikimi M, Roa NA, Yogi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46:849-854
20. Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid per-oxides in animal tissue by thiobarbituric acid. Anal Bio-chem 95:355-358
21. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ (2001) Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rattissues by reversing the altered glycolytic, gluconeogenic and lipo-genic enzymes. Mol Cell Biochem 244:45-51 (Pubitemid 32962651)
22. Sauerheber RD, Kuhn CE, Hyslop PA (1984) Membrane structural/functional properties of adipocytes from normal and streptozotocin-diabetic rats. Diabetes 33:258-265 (Pubitemid 14196216)
23. Sayed AA (2008) Thymoquinone protects tubular epithelial cells against tubular injury. Cell Biochem Funct 26:374-380
24. Sayed AA (2011) Ferulsinaic acid attenuation of AGEs extends life span of Caenorhabditis elegans. J Pharm Phar-macol 63:423-428
25. Sayed AA (2012) Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci (in press)
26. Sayed AA, El-Shaieb K, Mourad A (2012) Life span exten-sion of Caenorhabditis elegans by Novel pyrido perimidine drevative. Arch Pharmacal Res (in press)
27. Xue W, Lei J, Li X, Zhang R (2011) Trigonellafoenum grae-cum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr Res 31:555-562
28. Xue W, Li X, Zhang J, Liu Y, Wang Z, Zhang R (2007) Effect ofTrigonellafoenum graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 16:422-426 (Pubitemid 46524638)